Clinical Trial Update: Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating medroxyprogesterone acetate with or without entinostat before surgery in endometrioid endometrial cancer; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrioid Endometrial Adenocarcinoma

Drugs mentioned

• Entinostat (entinostat)
• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-06-02